Scientific reports · 2025
Computed tomography derived FFR and plaque features in prognosis of aortic stenosis combined with coronary artery disease after TAVR.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fang Yi, Qiu Miaohan, Sun Yu, Guo Ran, Yu Bo, Liu Bin, Sun Yingxian, Tong Qian, Liu Jihong, Pang Wenyue, Luan Bo, Wang Bin, Wang Geng, Li Yang, Liang Zhenyang, Xu Kai, Han Yaling
Аннотация
To assess the value of computed tomography angiography (CTA)-derived fractional flow reserve (CT-FFR) and high-risk plaque characteristics (HRPC) in the prediction of prognosis in patients with concomitant aortic stenosis (AS) and coronary artery disease (CAD) after transcatheter aortic valve replacement (TAVR). The study was a post hoc analysis from a multicenter TAVR registry. Patients with AS and obstructive CAD who underwent successful TAVR treatment were enrolled. The CT-FFR and HRPC were measured in coronary vessels with ≥ 50% stenosis lesions. The patients were then grouped according to CT-FFR (≤ 0.8 vs. >0.8) and HRPC (Yes vs. No) criteria. The primary outcome was major adverse cardiovascular events (MACE), a composite of cardiac death, nonfatal myocardial infarction, and ischemia-driven revascularization. The multivariable Cox proportional regression was used to identify independent predictors of MACE. To assess the combined prognostic value of CT-FFR and HRPC to OPT-CAD risk, receiver operating characteristic curves were used and the area under the curve (AUC) was determined. A total of 213 patients were enrolled. The mean age was 74.34 years and 125 (58.4%) were male. The patients with lower CT-FFR (≤ 0.8) had a higher rate of MACE compared with those with CT-FFR > 0.8 (11.9% vs. 2.3%, P = 0.011). However, there was no significant difference in MACE incidence (9.0% vs. 5.3%, P = 0.38) between patients with and without HRPC, respectively. The Cox regression model revealed that advanced age (hazard ratio [HR] 1.07, 95% confidence interval [CI] 1.003-1.15, P = 0.04), elevated NT-proBNP levels (HR 1.004, 95% CI 1.00-1.01, P = 0.046), and higher CT-FFR (HR 0.78, 95% CI 0.62-0.97, P = 0.03) were independent predictors of MACE. The optimal threshold value for predicting MACE using CT-FFR was determined to be 0.79. The performance in predicting MACE using the OPT-CAD score model was enhanced when both CT-FFR and HRPC were incorporated into the model [AUC 0.63 (0.49-0.76) vs. 0.74 (0.63-0.84), P = 0.04]. Pre-procedure CT-FFR was an independent predictor of MACE in patients with concomitant AS and CAD after TAVR.